Studies have shown that it can modulate dopaminergic receptor sensitivity and influence serotonin release, explaining the neuroprotective effects observed in animal models of brain injury and behavioral disorders
Ipamorelin launches ghrelin receptors, which can lead to heightened hunger signals
however, other factors, such as side effects and route of administration (most all GLP1 receptor agonists are administered via subcutaneous injection) can also contribute to patients discontinuing their GLP1 receptor agonists
Medical Disclaimer This website is for educational and informational purposes only
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al